Rheumatoid Arthritis is a major medical problem that affects millions. Xeophin has devised a funding pathway to develop the XeRA-1 Therapeutic for Rheumatoid Arthritis, however this offering represents much more than stake in a promising pharmaceutical. Xeophins’ unique approach to Biotech funding can change the paradigm of how medicine is financed. Xeophin is tokenizing 50% of the future royalties generated by XeRA-1, allowing its token holders to fund, and benefit from its success.
|Aug 18, 2018||/r/Xeophin is born|
Subreddit GrowthHow /r/Xeophin growth compares with growth of 2,290,345 other subreddits.
|No. 939,285||Fastest growing yesterday|
|No. 1,031,537||Fastest growing last 7 days|
|No. 1,088,421||Fastest growing last 30 days|
|No. 1,136,501||Fastest growing last 90 days|